BACKGROUND: Among patients with heart failure (HF), anxiety symptoms may co-exist with depressive symptoms. However, the extent of overlap and risk factors for anxiety symptoms have not been thoroughly described. PURPOSE: The aim of this study was to describe the coexistence of anxiety and depressive symptoms, and to determine the predictors of anxiety symptoms in patients with HF. METHODS: The sample consisted of 556 outpatients with HF (34% female, 62±12 years, 54% New York Heart Association (NYHA) class III/IV) enrolled in a multicenter HF quality of life registry. Anxiety symptoms were assessed with the Brief Symptom Inventory-anxiety subscale. Depressive symptoms were measured with the Beck Depression Inventory-II (BDI). We used a cut-point of 0.35 to categorize patients as having anxiety symptoms or no anxiety symptoms. Logistic regression was used to determine whether age, gender, minority status, educational level, functional status, comorbidities, depressive symptoms, and antidepressant use were predictors of anxiety symptoms. RESULTS: One-third of patients had both depressive and anxiety symptoms. There was a dose-response relationship between depressive symptoms and anxiety symptoms; higher levels of depressive symptoms were associated with a higher level of anxiety symptoms. Younger age (odds ratio (OR)= 0.97, p=0.004, 95% confidence interval (CI) 0.95-0.99) and depressive symptoms (OR =1.25, p<0.001, 95% CI 1.19-1.31) were independent predictors of anxiety symptoms. CONCLUSIONS: Patients with HF and depressive symptoms are at high risk for experiencing anxiety symptoms. Clinicians should assess these patients for comorbid anxiety symptoms. Research is needed to test interventions for both depressive and anxiety symptoms.
BACKGROUND: Among patients with heart failure (HF), anxiety symptoms may co-exist with depressive symptoms. However, the extent of overlap and risk factors for anxiety symptoms have not been thoroughly described. PURPOSE: The aim of this study was to describe the coexistence of anxiety and depressive symptoms, and to determine the predictors of anxiety symptoms in patients with HF. METHODS: The sample consisted of 556 outpatients with HF (34% female, 62±12 years, 54% New York Heart Association (NYHA) class III/IV) enrolled in a multicenter HF quality of life registry. Anxiety symptoms were assessed with the Brief Symptom Inventory-anxiety subscale. Depressive symptoms were measured with the Beck Depression Inventory-II (BDI). We used a cut-point of 0.35 to categorize patients as having anxiety symptoms or no anxiety symptoms. Logistic regression was used to determine whether age, gender, minority status, educational level, functional status, comorbidities, depressive symptoms, and antidepressant use were predictors of anxiety symptoms. RESULTS: One-third of patients had both depressive and anxiety symptoms. There was a dose-response relationship between depressive symptoms and anxiety symptoms; higher levels of depressive symptoms were associated with a higher level of anxiety symptoms. Younger age (odds ratio (OR)= 0.97, p=0.004, 95% confidence interval (CI) 0.95-0.99) and depressive symptoms (OR =1.25, p<0.001, 95% CI 1.19-1.31) were independent predictors of anxiety symptoms. CONCLUSIONS: Patients with HF and depressive symptoms are at high risk for experiencing anxiety symptoms. Clinicians should assess these patients for comorbid anxiety symptoms. Research is needed to test interventions for both depressive and anxiety symptoms.
Authors: Thomas Rutledge; Veronica A Reis; Sarah E Linke; Barry H Greenberg; Paul J Mills Journal: J Am Coll Cardiol Date: 2006-09-26 Impact factor: 24.094
Authors: Debra K Moser; Seongkum Heo; Kyoung Suk Lee; Muna Hammash; Barbara Riegel; Terry A Lennie; Cynthia Arslanian-Engoren; Gia Mudd-Martin; Nancy Albert; John Watkins Journal: Age Ageing Date: 2013-07-05 Impact factor: 10.668
Authors: Wei Jiang; Maragatha Kuchibhatla; Michael S Cuffe; Eric J Christopher; Jude D Alexander; Greg L Clary; Michael A Blazing; Laura H Gaulden; Robert M Califf; Ranga R Krishnan; Christopher M O'Connor Journal: Circulation Date: 2004-11-22 Impact factor: 29.690
Authors: Debra K Moser; Cynthia Arslanian-Engoren; Martha J Biddle; Misook Lee Chung; Rebecca L Dekker; Muna H Hammash; Gia Mudd-Martin; Abdullah S Alhurani; Terry A Lennie Journal: Curr Cardiol Rep Date: 2016-12 Impact factor: 2.931
Authors: Quin E Denfeld; Julie T Bidwell; Jill M Gelow; James O Mudd; Christopher V Chien; Shirin O Hiatt; Christopher S Lee Journal: Heart Lung Date: 2019-11-18 Impact factor: 2.210
Authors: Dariusz P Danel; Agnieszka E Siennicka; Pawel Fedurek; Tomasz Frackowiak; Piotr Sorokowski; Ewa A Jankowska; Boguslaw Pawlowski Journal: Am J Mens Health Date: 2017-02-13
Authors: Johan Gustav Lundgren; Örjan Dahlström; Gerhard Andersson; Tiny Jaarsma; Anita Kärner Köhler; Peter Johansson Journal: J Med Internet Res Date: 2016-08-03 Impact factor: 5.428
Authors: Edita Lycholip; Ina Thon Aamodt; Irene Lie; Toma Šimbelytė; Roma Puronaitė; Hans Hillege; Arjen de Vries; Imke Kraai; Anna Stromberg; Tiny Jaarsma; Jelena Čelutkienė Journal: Patient Prefer Adherence Date: 2018-06-26 Impact factor: 2.711